Cargando…

Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells

Ran Binding Protein 9 (RanBP9, also known as RanBPM) is an evolutionary conserved scaffold protein present both in the nucleus and the cytoplasm of cells whose biological functions remain elusive. We show that active ATM phosphorylates RanBP9 on at least two different residues (S181 and S603). In re...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmieri, Dario, Scarpa, Mario, Tessari, Anna, Uka, Rexhep, Amari, Foued, Lee, Cindy, Richmond, Timothy, Foray, Claudia, Sheetz, Tyler, Braddom, Ashley, Burd, Christin E., Parvin, Jeffrey D., Ludwig, Thomas, Croce, Carlo M., Coppola, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951294/
https://www.ncbi.nlm.nih.gov/pubmed/26943034
http://dx.doi.org/10.18632/oncotarget.7813
_version_ 1782443678095114240
author Palmieri, Dario
Scarpa, Mario
Tessari, Anna
Uka, Rexhep
Amari, Foued
Lee, Cindy
Richmond, Timothy
Foray, Claudia
Sheetz, Tyler
Braddom, Ashley
Burd, Christin E.
Parvin, Jeffrey D.
Ludwig, Thomas
Croce, Carlo M.
Coppola, Vincenzo
author_facet Palmieri, Dario
Scarpa, Mario
Tessari, Anna
Uka, Rexhep
Amari, Foued
Lee, Cindy
Richmond, Timothy
Foray, Claudia
Sheetz, Tyler
Braddom, Ashley
Burd, Christin E.
Parvin, Jeffrey D.
Ludwig, Thomas
Croce, Carlo M.
Coppola, Vincenzo
author_sort Palmieri, Dario
collection PubMed
description Ran Binding Protein 9 (RanBP9, also known as RanBPM) is an evolutionary conserved scaffold protein present both in the nucleus and the cytoplasm of cells whose biological functions remain elusive. We show that active ATM phosphorylates RanBP9 on at least two different residues (S181 and S603). In response to IR, RanBP9 rapidly accumulates into the nucleus of lung cancer cells, but this nuclear accumulation is prevented by ATM inhibition. RanBP9 stable silencing in three different lung cancer cell lines significantly affects the DNA Damage Response (DDR), resulting in delayed activation of key components of the cellular response to IR such as ATM itself, Chk2, γH2AX, and p53. Accordingly, abrogation of RanBP9 expression reduces homologous recombination-dependent DNA repair efficiency, causing an abnormal activation of IR-induced senescence and apoptosis. In summary, here we report that RanBP9 is a novel mediator of the cellular DDR, whose accumulation into the nucleus upon IR is dependent on ATM kinase activity. RanBP9 absence hampers the molecular mechanisms leading to efficient repair of damaged DNA, resulting in enhanced sensitivity to genotoxic stress. These findings suggest that targeting RanBP9 might enhance lung cancer cell sensitivity to genotoxic anti-neoplastic treatment.
format Online
Article
Text
id pubmed-4951294
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-49512942016-07-21 Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells Palmieri, Dario Scarpa, Mario Tessari, Anna Uka, Rexhep Amari, Foued Lee, Cindy Richmond, Timothy Foray, Claudia Sheetz, Tyler Braddom, Ashley Burd, Christin E. Parvin, Jeffrey D. Ludwig, Thomas Croce, Carlo M. Coppola, Vincenzo Oncotarget Research Paper Ran Binding Protein 9 (RanBP9, also known as RanBPM) is an evolutionary conserved scaffold protein present both in the nucleus and the cytoplasm of cells whose biological functions remain elusive. We show that active ATM phosphorylates RanBP9 on at least two different residues (S181 and S603). In response to IR, RanBP9 rapidly accumulates into the nucleus of lung cancer cells, but this nuclear accumulation is prevented by ATM inhibition. RanBP9 stable silencing in three different lung cancer cell lines significantly affects the DNA Damage Response (DDR), resulting in delayed activation of key components of the cellular response to IR such as ATM itself, Chk2, γH2AX, and p53. Accordingly, abrogation of RanBP9 expression reduces homologous recombination-dependent DNA repair efficiency, causing an abnormal activation of IR-induced senescence and apoptosis. In summary, here we report that RanBP9 is a novel mediator of the cellular DDR, whose accumulation into the nucleus upon IR is dependent on ATM kinase activity. RanBP9 absence hampers the molecular mechanisms leading to efficient repair of damaged DNA, resulting in enhanced sensitivity to genotoxic stress. These findings suggest that targeting RanBP9 might enhance lung cancer cell sensitivity to genotoxic anti-neoplastic treatment. Impact Journals LLC 2016-03-01 /pmc/articles/PMC4951294/ /pubmed/26943034 http://dx.doi.org/10.18632/oncotarget.7813 Text en Copyright: © 2016 Palmieri et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Palmieri, Dario
Scarpa, Mario
Tessari, Anna
Uka, Rexhep
Amari, Foued
Lee, Cindy
Richmond, Timothy
Foray, Claudia
Sheetz, Tyler
Braddom, Ashley
Burd, Christin E.
Parvin, Jeffrey D.
Ludwig, Thomas
Croce, Carlo M.
Coppola, Vincenzo
Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells
title Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells
title_full Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells
title_fullStr Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells
title_full_unstemmed Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells
title_short Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells
title_sort ran binding protein 9 (ranbp9) is a novel mediator of cellular dna damage response in lung cancer cells
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951294/
https://www.ncbi.nlm.nih.gov/pubmed/26943034
http://dx.doi.org/10.18632/oncotarget.7813
work_keys_str_mv AT palmieridario ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells
AT scarpamario ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells
AT tessarianna ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells
AT ukarexhep ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells
AT amarifoued ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells
AT leecindy ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells
AT richmondtimothy ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells
AT forayclaudia ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells
AT sheetztyler ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells
AT braddomashley ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells
AT burdchristine ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells
AT parvinjeffreyd ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells
AT ludwigthomas ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells
AT crocecarlom ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells
AT coppolavincenzo ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells